| SS/NEisSlc |
systolic blood pressure |
controlled sodium content diet (8 %) (for 28 days) then adrenalectomy then controlled sodium content diet (0.3 %) (for 28 days) and dexamethasone (20 ug/d) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
arterial blood pressure trait |
male |
98.0 days
| 4 |
|
|
141.0 |
mmHg |
8.0 |
16.0 |
tail cuff plethysmography |
|
0.0 |
|
69688 |
736 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 84 days) |
Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. |
arterial blood pressure trait |
male |
126.0 days
| 10 |
undefined |
|
249.0 |
mmHg |
5.06 |
16.0 |
tail cuff plethysmography |
|
0.0 |
|
102495 |
2690 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then tolvaptan (0.05 %) (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
arterial blood pressure trait |
male |
126.0 days
| 8 |
undefined |
|
235.0 |
mmHg |
13.0 |
36.77 |
tail cuff plethysmography |
|
0.0 |
|
102315 |
2684 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 77 days) then vehicle control condition (for 49 days) |
Ishikawa M, et al., Int Heart J. 2013;54(2):98-106. |
arterial blood pressure trait |
male |
126.0 days
| 8 |
undefined |
|
226.0 |
mmHg |
11.0 |
31.11 |
tail cuff plethysmography |
|
0.0 |
|
102314 |
2684 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium chloride content diet (8 %) (for 7 days) |
Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. |
arterial blood pressure trait |
male |
63.0 days
| 8 |
mean of 3 samples of undefined duration |
serial mean |
126.0 |
mmHg |
2.12 |
6.0 |
tail cuff plethysmography |
|
0.0 |
|
102430 |
2689 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium chloride content diet (8 %) (for 14 days) |
Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. |
arterial blood pressure trait |
male |
70.0 days
| 7 |
mean of 3 samples of undefined duration |
serial mean |
166.0 |
mmHg |
1.89 |
5.0 |
tail cuff plethysmography |
|
0.0 |
|
102432 |
2689 |
| SS/NEisSlc |
systolic blood pressure |
controlled E4177 content drinking water (25 ug/ml) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547.0 days
| 10 |
|
|
132.0 |
mmHg |
3.0 |
9.49 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
106790 |
2339 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium content diet (8 %) (for 28 days) then controlled sodium content diet (0.3 %) (for 28 days) |
Kitada K, et al., PLoS One. 2012;7(7):e41896. Epub 2012 Jul 24. |
arterial blood pressure trait |
male |
98.0 days
| 10 |
|
|
144.0 |
mmHg |
4.0 |
12.65 |
tail cuff plethysmography |
|
0.0 |
|
69687 |
736 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium chloride content diet (0.3 %) (for 42 days) then controlled sodium chloride content diet (8 %) (for 35 days) |
Horinaka S, et al., Int J Cardiol. 2003 Sep;91(1):25-35. |
arterial blood pressure trait |
male |
77.0 days
| 10 |
undefined |
|
233.0 |
mmHg |
0.63 |
2.0 |
tail cuff plethysmography |
|
0.0 |
|
102494 |
2690 |
| SS/NEisSlc |
systolic blood pressure |
controlled cilazapril content drinking water (2.5 ug/ml) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547.0 days
| 10 |
|
|
136.0 |
mmHg |
3.0 |
9.49 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
106788 |
2339 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium chloride content diet (8 %) (for 21 days) then 0.9% sodium chloride solution (for 21 days) |
Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. |
arterial blood pressure trait |
male |
77.0 days
| 14 |
mean of 3 samples of undefined duration |
serial mean |
173.0 |
mmHg |
2.67 |
10.0 |
tail cuff plethysmography |
|
0.0 |
|
102466 |
2689 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium chloride content diet (8 %) (for 21 days) |
Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. |
arterial blood pressure trait |
male |
77.0 days
| 8 |
mean of 3 samples of undefined duration |
serial mean |
169.0 |
mmHg |
2.47 |
7.0 |
tail cuff plethysmography |
|
0.0 |
|
102434 |
2689 |
| SS/NEisSlc |
systolic blood pressure |
controlled cilazapril content drinking water (12.5 ug/ml) (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547.0 days
| 10 |
|
|
122.0 |
mmHg |
4.0 |
12.65 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
106789 |
2339 |
| SS/NEisSlc |
systolic blood pressure |
controlled sodium chloride content diet (8 %) (for 21 days) then adrenomedulin (9.6 ug/d) (for 21 days) |
Yoshihara F, et al., Regul Pept. 2005 May 15;128(1):7-13. |
arterial blood pressure trait |
male |
77.0 days
| 14 |
mean of 3 samples of undefined duration |
serial mean |
150.0 |
mmHg |
2.67 |
10.0 |
tail cuff plethysmography |
|
0.0 |
|
102467 |
2689 |
| SS/NEisSlc |
systolic blood pressure |
vehicle control condition (for 547.5 days) |
Hirawa N, et al., Hypertension. 1999 Sep;34(3):496-502. |
arterial blood pressure trait |
not specified |
547.0 days
| 10 |
|
|
137.0 |
mmHg |
3.0 |
9.49 |
vascular indwelling catheter method |
femoral artery |
0.0 |
|
106791 |
2339 |